TNF-α −308G/A (rs1800629) polymorphism and susceptibility to anogenital warts and their recurrence in Uzbek women from the Aral Sea Basin: a preliminary case–control study

Authors

Keywords:

anogenital warts, human papillomavirus, TNF-α, rs1800629, gene polymorphism, recurrence, Uzbekistan.

Abstract

Abstract

Background: Anogenital warts caused by human papillomavirus follow a chronic, frequently relapsing course, and host immunogenetic factors may influence susceptibility and recurrence. The aim of this study was to examine the distribution of TNF-α rs1800629 (−308 G/A) alleles and genotypes in women with anogenital warts from the Aral Sea basin and to assess their possible association with disease susceptibility and recurrence.

The study material comprised venous blood samples obtained from 101 women with clinically confirmed anogenital warts (recurrent, n = 66; non-recurrent, n = 35) and 95 age- and ethnicity-matched healthy controls. Genotyping was performed by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP); allele and genotype frequencies were compared using the χ² test with calculation of odds ratios and 95% confidence intervals.

The results revealed a low frequency of the minor A allele in both groups (6.9% versus 5.8%) and complete absence of the A/A genotype. No statistically significant differences were observed between patients and controls (OR = 1.2; 95% CI: 0.53–2.86; p = 0.70) or between the recurrent and non-recurrent subgroups.

The obtained findings indicate the absence of a major independent contribution of TNF-α rs1800629 to susceptibility to anogenital warts and their recurrence in this population; the low minor-allele frequency limits statistical power, and confirmation in larger multicentre studies is required.

Author Biography

Yusupova Sh.A., Urgench State Medical Institute

Dotsent, PhD

References

Malagón T, Franco EL, Tejada R, et al. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat Rev Clin Oncol. 2024;21:522–538. doi:10.1038/s41571-024-00904-z.

Martín E, Reina G, Carlos S. Advances in therapeutic vaccines against HPV: a review of human clinical trials. Curr Oncol. 2025;32(11):600. doi:10.3390/curroncol32110600.

Whitworth HS, Mounier-Jack S, Choi EM, et al. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: an updated systematic review of evidence from clinical trials. Vaccine X. 2024;19:100486. doi:10.1016/j.jvacx.2024.100486.

Prieto-Islas MA, Godoy-Dahbura E, Villalpando-Sánchez DC, et al. HPV vaccination improves immune response in children with respiratory papillomatosis. Sci Rep. 2025;15:29885. doi:10.1038/s41598-025-14787-2.

Williamson AL. Recent developments in human papillomavirus (HPV) vaccinology. Viruses. 2023;15(7):1440. doi:10.3390/v15071440.

Shiri Aghbash P, Rasizadeh R, Sadri Nahand J, Bannazadeh Baghi H. The role of immune cells and inflammasomes in modulating cytokine responses in HPV-related cervical cancer. Int Immunopharmacol. 2025;145:113625. doi:10.1016/j.intimp.2024.113625.

Goulenok T, Sacré K. HPV infection and prevention in patients with immune-mediated inflammatory diseases: a scoping review. J Clin Rheumatol. 2024;30(7S Suppl 1):S34–S41. doi:10.1097/RHU.0000000000002122.

Yan S, Zhang X, Lin Q, et al. Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13+ CD4+ T cell activation in oropharyngeal cancer: implications for immunotherapy. Cancer Immunol Immunother. 2024;73:206. doi:10.1007/s00262-024-03789-0.

Marzbanrad Z, Heidari F, Khayamzadeh M, et al. A comprehensive integration of data regarding the correlation of TNF-α rs1800629 polymorphism with susceptibility to cervical cancer. Asian Pac J Cancer Prev. 2024;25(4):1155–1167. doi:10.31557/APJCP.2024.25.4.1155.

El Mansouri N, Rogua H, Ferrera L, et al. Influence of TNFα and IL-10 polymorphisms on HPV-related cervical carcinogenesis risk among southern Moroccan women. Gene Rep. 2024;36:101970. doi:10.1016/j.genrep.2024.101970.

Lu Y, Wu Q, Wang L, et al. Chlamydia trachomatis enhances HPV persistence through immune modulation. BMC Infect Dis. 2024;24:229. doi:10.1186/s12879-024-09094-6.

Downloads

Published

2026-10-31

How to Cite

1.
Yusupova Sh.A. TNF-α −308G/A (rs1800629) polymorphism and susceptibility to anogenital warts and their recurrence in Uzbek women from the Aral Sea Basin: a preliminary case–control study. MMI [Internet]. 2026 Oct. 31 [cited 2026 Nov. 19];1(1):167-80. Available from: https://urdti-mmi.uz/index.php/MMI/article/view/25